Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Japanese drugmaker Astellas Pharma says it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labor ...

Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) ...

Japan's real wages fell 0.2 percent from a year earlier in 2024, marking the third consecutive year of decline, as pay hikes ...

Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy: Tokyo Thursday, February 6, 2025, 09:00 Hrs [IST] Aste ...

Japan's December inflation-adjusted real wages rose 0.6 per cent year-on-year thanks to a wintertime bonus bump, preliminary ...

More than 40 per cent of Japanese individuals wish to continue using their original surnames at work after marriage, according to ...

(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP for ...

The <a href=" "target="_blank">Ministry of Foreign Affairs organized a practical workshop for officials from 12 key sectors ...

Japanese nominal wages rose at the fastest pace in nearly three decades, supporting the Bank of Japan’s latest rate hike decision and keeping the bank on track for further tightening steps.  Nominal ...

Japanese nominal wages rose at the fastest pace in nearly three decades, supporting the Bank of Japan’s (BoJ) latest rate ...

Asian stock markets churned Wednesday on evolving China-US trade tensions and after tempered earnings-reports overnight from US-based tech titans Alphabet (GOOG, GOOGL) and Advanced Micro Devices (AMD ...